{
  "id": 12454,
  "url": "https://www.cnbc.com/2026/07/22/axiom-aiosciences-ipo-listing-hong-kong.html",
  "title": "Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first",
  "summary": "Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.",
  "authors": null,
  "category": "news",
  "topics": "finance-investment,biotech",
  "orgs": null,
  "regions": "china",
  "published_at": "2026-07-22T00:15:19.000Z",
  "fetched_at": "2026-07-22T05:10:49.469Z",
  "source_slug": "x-cnbc-technology",
  "source_name": "CNBC Technology",
  "source_homepage": "https://www.cnbc.com/technology/",
  "ethics_ai_record_url": "https://ethics.ai/record/12454",
  "original_url": "https://www.cnbc.com/2026/07/22/axiom-aiosciences-ipo-listing-hong-kong.html",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}